Former University of Alabama Athletic Director’s Family Files Alabama Wrongful Death Lawsuit
April 7th, 2015|
Drug manufacturers have a responsibility to warn patients and doctors about the side effects of their products. Furthermore, these businesses can only market their products to patients suffering from conditions for which their drug has been approved by the U.S. Food and Drug Administration to treat.
An Alabama wrongful death lawsuit filed by the daughter of the former Athletic Director for the University of Alabama, Mal Moore, addresses both of these issues. The lawsuit claims the makers of the drug amiodarone are responsible for Moore’s death because they failed to warn him about the side effects of the drug. The drug was also used to treat a condition that it was not fully approved to treat.
According to an article from Yahoo! News, Moore took amiodarone for roughly three months to treat a non-life threatening irregular heartbeat. However, the medication was only approved as “a drug of last resort” with a potential for serious side effects when used to treat Moore’s condition. Moore also reportedly suffered many of the side effects the drug posed, but he was unaware of the risk because he was never warned prior to beginning his regimen.
The family is seeking an undisclosed amount in damages for their loss.
At Norris Injury Lawyers, we know how devastating the untimely loss of a loved one can be, which is why our Birmingham personal injury attorneys are hopeful this lawsuit helps bring a sense of closure to the family of the victim.